Abstract
Cerebral creatine deficiency syndromes (CCDSs) are a group of inborn errors of creatine metabolism comprising two autosomal recessive disorders that affect the biosynthesis of creatine – i.e. arginine:glycine amidinotransferase deficiency (AGAT; MIM 602360) and guanidinoacetate methyltransferase deficiency (GAMT; MIM 601240) – and an X-linked defect that affects the creatine transporter, SLC6A8 deficiency (SLC6A8; MIM 300036). The biochemical hallmarks of these disorders include cerebral creatine deficiency as detected in vivo by 1H magnetic resonance spectroscopy (MRS) of the brain, and specific disturbances in metabolites of creatine metabolism in body fluids. In urine and plasma, abnormal guanidinoacetic acid (GAA) levels are found in AGAT deficiency (reduced GAA) and in GAMT deficiency (increased GAA). In urine of males with SLC6A8 deficiency, an increased creatine/creatinine ratio is detected. The common clinical presentation in CCDS includes mental retardation, expressive speech and language delay, autistic like behaviour and epilepsy. Treatment of the creatine biosynthesis defects has yielded clinical improvement, while for creatine transporter deficiency, successful treatment strategies still need to be discovered. CCDSs may be responsible for a considerable fraction of children and adults affected with mental retardation of unknown etiology. Thus, screening for this group of disorders should be included in the differential diagnosis of this population. In this review, also the importance of CCDSs for the unravelling of the (patho)physiology of cerebral creatine metabolism is discussed
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Almeida, L.S., Rosenberg, E.H., Verhoeven, N.M., Jakobs, C., and Salomons, G.S., 2006a, Are cerebral creatine deficiency syndromes on the radar screen? Future Neurol. 1: 637–649.
Almeida, L.S., Salomons, G.S., Hogenboom, F., Jakobs, C., and Schoffelmeer, A.N., 2006b, Exocytotic release of creatine in rat brain. Synapse 60: 118–123.
Almeida, L.S., Verhoeven, N.M., Roos, B., Valongo, C., Cardoso, M.L., Vilarinho, L., Salomons, G.S., and Jakobs, C., 2004, Creatine and guanidinoacetate: diagnostic markers for inborn errors in creatine biosynthesis and transport. Mol. Genet. Metab. 82: 214–219.
Almeida, L.S., Vilarinho, L., Darmin, P.S., Rosenberg, E.H., Martinez-Munoz, C., Jakobs, C., and Salomons, G.S., 2007, A prevalent pathogenic GAMT mutation (c.59G > C) in Portugal. Mol. Genet. Metab. 91: 1–6.
Anselm, I.A., Alkuraya, F.S., Salomons, G.S., Jakobs, C., Fulton, A.B., Mazumdar, M., Rivkin, M., Frye, R., Poussaint, T.Y., and Marsden, D., 2006, X-linked creatine transporter defect: a report on two unrelated boys with a severe clinical phenotype. J. Inherit. Metab. Dis. 29: 214–219.
Battini, R., Alessandri, M.G., Leuzzi, V., Moro, F., Tosetti, M., Bianchi, M.C., and Cioni, G., 2006, Arginine:glycine amidinotransferase (AGAT) deficiency in a newborn: early treatment can prevent phenotypic expression of the disease. J. Pediatr. 148: 828–830.
Battini, R., Leuzzi, V., Carducci, C., Tosetti, M., Bianchi, M.C., Item, C.B., Stöckler-Ipsiroglu, S., and Cioni, G., 2002, Creatine depletion in a new case with AGAT deficiency: clinical and genetic study in a large pedigree. Mol. Genet. Metab. 77: 326–331.
Bianchi, M.C., Tosetti, M., Fornai, F., Alessandri’, M.G., Cipriani, P., De, V.G., and Canapicchi, R., 2000, Reversible brain creatine deficiency in two sisters with normal blood creatine level. Ann. Neurol. 47: 511–513.
Braissant, O., Henry, H., Loup, M., Eilers, B., and Bachmann, C., 2001, Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study. Brain Res. Mol. Brain Res. 86: 193–201.
Braissant, O., Henry, H., Villard, A.M., Zurich, M.G., Loup, M., Eilers, B., Parlascino, G., Matter, E., Boulat, O., Honegger, P., and Bachmann, C., 2002, Ammonium-induced impairment of axonal growth is prevented through glial creatine. J. Neurosci. 22: 9810–9820.
Braissant, O., Henry, H., Villard, A.M., Speer, O., Wallimann, T., and Bachmann, C., 2005, Creatine synthesis and transport during rat embryogenesis: spatiotemporal expression of AGAT, GAMT and CT1. BMC Dev. Biol. 5: 9.
Braissant, O., Bachmann, C., and Henry, H., 2007, Expression and function of AGAT, GAMT and CT1 in the mammalian brain. Subcell. Biochem. 46: 67–81.
Brewer, G.J., and Wallimann, T.W., 2000, Protective effect of the energy precursor creatine against toxicity of glutamate and beta-amyloid in rat hippocampal neurons. J. Neurochem. 74: 1968–1978.
Cecil, K.M., Salomons, G.S., Ball, W.S., Jr., Wong, B., Chuck, G., Verhoeven, N.M., Jakobs, C., and Degrauw, T.J., 2001, Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect? Ann. Neurol. 49: 401–404.
Christie, D.L., 2007, Functional insights into the creatine transporter. Subcell. Biochem. 46: 99–118.
Clark, A.J., Rosenberg, E.H., Almeida, L.S., Wood, T.C., Jakobs, C., Stevenson, R.E., Schwartz, C.E., and Salomons, G.S., 2006, X-linked creatine transporter (SLC6A8) mutations in about 1{%} of males with mental retardation of unknown etiology. Hum. Genet. 119: 604–610.
De Deyn, P.P., D’Hooge, R., Van Bogaert, P.P., and Marescau, B., 2001, Endogenous guanidino compounds as uremic neurotoxins. Kidney Int. Suppl. 78: S77–S83.
De Vries, M., Morava, E., Rodenburg, R., Kluijtmans, L., Verhoeven, N.M., Salomons, G.S., Jakobs, C., and Smeitink, J., 2005, Mitochondrial dysfunction in creatine biosynthesis disorder. J. Inherit. Metab. Dis. 28: 227.
DeGrauw, T.J., Cecil, K.M., Byars, A.W., Salomons, G.S., Ball, W.S., and Jakobs, C., 2003, The clinical syndrome of creatine transporter deficiency. Mol. Cell. Biochem. 244: 45–48.
DeGrauw, T.J., Salomons, G.S., Cecil, K.M., Chuck, G., Newmeyer, A., Schapiro, M.B., and Jakobs, C., 2002, Congenital creatine transporter deficiency. Neuropediatrics 33: 232–238.
Dolder, M., Walzel, B., Speer, O., Schlattner, U., and Wallimann, T., 2003, Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation. J. Biol. Chem. 278: 17760–17766.
Dringen, R., Verleysdonk, S., Hamprecht, B., Willker, W., Leibfritz, D., and Brand, A., 1998, Metabolism of glycine in primary astroglial cells: synthesis of creatine, serine, and glutathione. J. Neurochem. 70: 835–840.
Item, C.B., Stöckler-Ipsiroglu, S., Stromberger, C., Muhl, A., Alessandri, M.G., Bianchi, M.C., Tosetti, M., Fornai, F., and Cioni, G., 2001, Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans. Am. J. Hum. Genet. 69: 1127–1133.
Jinnai, D., Sawai, A., and Mori, A., 1966, Gamma-guanidinobutyric acid as a convulsive substance. Nature 212: 617.
Juravleva, E., Barbakadze, T., Mikeladze, D., and Kekelidze, T., 2005, Creatine enhances survival of glutamate-treated neuronal/glial cells, modulates Ras/NF-$\UPkappa $B signaling, and increases the generation of reactive oxygen species. J. Neurosci. Res. 79: 224–230.
Kleefstra, T., Rosenberg, E.H., Salomons, G.S., Stroink, H., van Bokhoven, H., Hamel, B.C., and de Vries, B.B., 2005, Progressive intestinal, neurological and psychiatric problems in two adult males with cerebral creatine deficiency caused by an SLC6A8 mutation. Clin. Genet. 68: 379–381.
Klivenyi, P., Ferrante, R.J., Matthews, R.T., Bogdanov, M.B., Klein, A.M., Andreassen, O.A., Mueller, G., Wermer, M., Kaddurah-Daouk, R., and Beal, M.F., 1999, Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat. Med. 5: 347–350.
Koga, Y., Takahashi, H., Oikawa, D., Tachibana, T., Denbow, D.M., and Furuse, M., 2005, Brain creatine functions to attenuate acute stress responses through GABAnergic system in chicks. Neuroscience 132: 65–71.
Limberger, N., Spath, L., and Starke, K., 1986, Release of previously incorporated \UPgamma -[3H]aminobutyric acid in rabbit caudate nucleus slices. J. Neurochem. 46: 1102–1108.
Lion-Francois, L., Cheillan, D., Pitelet, G., Acquaviva-Bourdain, C., Bussy, G., Cotton, F., Guibaud, L., Gerard, D., Rivier, C., Vianey-Saban, C., Jakobs, C., Salomons, G.S., and des Portes, V., 2006, High frequency of creatine deficiency syndromes in patients with unexplained mental retardation. Neurology 67: 1713–1714.
Loike, J.D., Zalutsky, D.L., Kaback, E., Miranda, A.F., and Silverstein, S.C., 1988, Extracellular creatine regulates creatine transport in rat and human muscle cells. Proc. Natl. Acad. Sci. USA\break 85: 807–811.
Mancini, G.M., Catsman-Berrevoets, C.E., de Coo, I.F., Aarsen, F.K., Kamphoven, J.H., Huijmans, J.G., Duran, M., van der Knaap, M.S., Jakobs, C., and Salomons, G.S., 2005, Two novel mutations in SLC6A8 cause creatine transporter defect and distinctive X-linked mental retardation in two unrelated Dutch families. Am. J. Med. Genet. A 132: 288–295.
Matthews, R.T., Ferrante, R.J., Klivenyi, P., Yang, L., Klein, A.M., Mueller, G., Kaddurah-Daouk, R., and Beal, M.F., 1999, Creatine and cyclocreatine attenuate MPTP neurotoxicity. Exp. Neurol. 157: 142–149.
Matthews, R.T., Yang, L., Jenkins, B.G., Ferrante, R.J., Rosen, B.R., Kaddurah-Daouk, R., and Beal, M.F., 1998, Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington’s disease. J. Neurosci. 18: 156–163.
Mercimek-Mahmutoglu, S., Muehl, A., Salomons, G.S., Waldhoer, T., Neophytou, B., Jakobs, C., and Stoeckler-Ipsiroglu, S., 2007, Simultaneous determination of urinary creatine and creatinine by electrospray tandem mass spectrometry for screening of X-linked creatine transporter (SLC6A8) deficiency. Submitted for publication.
Mercimek-Mahmutoglu, S., Stoeckler-Ipsiroglu, S., Adami, A., Appleton, R., Araujo, H.C., Duran, M., Ensenauer, R., Fernandez-Alvarez, E., Garcia, P., Grolik, C., Item, C.B., Leuzzi, V., Marquardt, I., Muhl, A., Saelke-Kellermann, R.A., Salomons, G.S., Schulze, A., Surtees, R., van der Knaap, M.S., Vasconcelos, R., Verhoeven, N.M., Vilarinho, L., Wilichowski, E., and Jakobs, C., 2006, GAMT deficiency: features, treatment, and outcome in an inborn error of creatine synthesis. Neurology 67: 480–484.
Neu, A., Neuhoff, H., Trube, G., Fehr, S., Ullrich, K., Roeper, J., and Isbrandt, D., 2002, Activation of GABA$A$ receptors by guanidinoacetate: a novel pathophysiological mechanism. Neurobiol. Dis. 11: 298–307.
Newmeyer, A., Cecil, K.M., Schapiro, M., Clark, J.F., and Degrauw, T.J., 2005, Incidence of brain creatine transporter deficiency in males with developmental delay referred for brain magnetic resonance imaging. J. Dev. Behav. Pediatr. 26: 276–282.
Peral, M.J., Garcia-Delgado, M., Calonge, M.L., Duran, J.M., De La Horra, M.C., Wallimann, T., Speer, O., and Ilundain, A., 2002, Human, rat and chicken small intestinal Na+-Cl--creatine transporter: functional, molecular characterization and localization. J. Physiol. 545: 133–144.
Poo-Arguelles, P., Arias, A., Vilaseca, M.A., Ribes, A., Artuch, R., Sans-Fito, A., Moreno, A., Jakobs, C., and Salomons, G., 2006, X-Linked creatine transporter deficiency in two patients with severe mental retardation and autism. J. Inherit. Metab. Dis. 29: 220–223.
Pyne-Geithman, G.J., Degrauw, T.J., Cecil, K.M., Chuck, G., Lyons, M.A., Ishida, Y., and Clark, J.F., 2004, Presence of normal creatine in the muscle of a patient with a mutation in the creatine transporter: a case study. Mol. Cell. Biochem. 262: 35–39.
Renema, W.K., Schmidt, A., van Asten, J.J., Oerlemans, F., Ullrich, K., Wieringa, B., Isbrandt, D., and Heerschap, A., 2003, MR spectroscopy of muscle and brain in guanidinoacetate methyltransferase (GAMT)-deficient mice: validation of an animal model to study creatine deficiency. Magn. Reson. Med. 50: 936–943.
Rosenberg, E.H., Martínez Muñoz, C., Betsalel, O.T., van Dooren, S.J., Fernandez, M., Jakobs, C., deGrauw, T.J., Kleefstra, T., Schwartz, C.E., and Salomons, G.S., 2007, Functional characterization of missense variants in creatine transporter/SLC6A8: improved diagnostic application. Hum. Mutat., in press.
Rosenberg, E.H., Almeida, L.S., Kleefstra, T., deGrauw, R.S., Yntema, H.G., Bahi, N., Moraine, C., Ropers, H.H., Fryns, J.P., deGrauw, T.J., Jakobs, C., and Salomons, G.S., 2004, High prevalence of SLC6A8 deficiency in X-linked mental retardation. Am. J. Hum. Genet. 75: 97–105.
Salomons, G.S., van Dooren, S.J., Verhoeven, N.M., Cecil, K.M., Ball, W.S., Degrauw, T.J., and Jakobs, C., 2001, X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome. Am. J. Hum. Genet. 68: 1497–1500.
Schmidt, A., Marescau, B., Boehm, E.A., Renema, W.K., Peco, R., Das, A., Steinfeld, R., Chan, S., Wallis, J., Davidoff, M., Ullrich, K., Waldschutz, R., Heerschap, A., De Deyn, P.P., Neubauer, S., and Isbrandt, D., 2004, Severely altered guanidino compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiency. Hum. Mol. Genet. 13: 905–921.
Schoffelmeer, A.N., Wemer, J., Mulder, A.H., 1981, Comparison between electrically evoked and potassium-induced 3H-noradrenaline release from rat neocortex slices: role of calcium ions and transmitter pools. Neurochem. Int. 3: 129–136.
Schulze, A., Mayatepek, E., Bachert, P., Marescau, B., De Deyn, P.P., and Rating, D., 1998, Therapeutic trial of arginine restriction in creatine deficiency syndrome. Eur. J. Pediatr. 157: 606–607.
Schulze, A., Bachert, P., Schlemmer, H., Harting, I., Polster, T., Salomons, G.S., Verhoeven, N.M., Jakobs, C., Fowler, B., Hoffmann, G.F., and Mayatepek, E., 2003, Lack of creatine in muscle and brain in an adult with GAMT deficiency. Ann. Neurol. 53: 248–251.
Schulze, A., Hoffmann, G.F., Bachert, P., Kirsch, S., Salomons, G.S., Verhoeven, N.M., and Mayatepek, E., 2006, Presymptomatic treatment of neonatal guanidinoacetate methyltransferase deficiency. Neurology 67: 719–721.
Schulze, A., and Battini, R., 2007, Pre-symptomatic treatment of creatine biosynthesis defects. Subcell. Biochem. 46: 167–181.
Speer, O., Neukomm, L.J., Murphy, R.M., Zanolla, E., Schlattner, U., Henry, H., Snow, R.J., and Wallimann, T., 2004, Creatine transporters: a reappraisal. Mol. Cell. Biochem. 256–257: 407–424.
Stöckler, S., Holzbach, U., Hanefeld, F., Marquardt, I., Helms, G., Requart, M., Hanicke, W., and Frahm, J., 1994, Creatine deficiency in the brain: a new, treatable inborn error of metabolism. Pediatr. Res. 36: 409–413.
Stöckler, S., Hanefeld, F., and Frahm, J., 1996a, Creatine replacement therapy in guanidinoacetate methyltransferase deficiency, a novel inborn error of metabolism. Lancet 348: 789–790.
Stöckler, S., Isbrandt, D., Hanefeld, F., Schmidt, B., and von Figura, K., 1996b, Guanidinoacetate methyltransferase deficiency: the first inborn error of creatine metabolism in man. Am. J. Hum. Genet. 58: 914–922.
Stöckler, S., Marescau, B., De Deyn, P.P., Trijbels, J.M., and Hanefeld, F., 1997, Guanidino compounds in guanidinoacetate methyltransferase deficiency, a new inborn error of creatine synthesis. Metabolism 46: 1189–1193.
Stöckler-Ipsiroglu, S., and Salomons, G.S., 2006, Creatine deficiency syndromes. In: Fernandes, J., Saudubray, J.-M., van den Berghe, G., and Walter, J.H., eds., Inborn Metabolic Diseases, Diagnosis and Treatment, Springer, Heidelberg, Germany, pp. 211–217.
Tachikawa, M., Fukaya, M., Terasaki, T., Ohtsuki, S., and Watanabe, M., 2004, Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK-Mi and CK-B suggest a novel neuron-glial relationship for brain energy homeostasis. Eur. J. Neurosci. 20: 144–160.
Tachikawa, M., Hosoya, K.-i., Ohtsuki, S., and Terasaki, T., 2007, A novel relationship between creatine transport at the blood-brain and blood-retinal barriers, creatine biosynthesis, and its use for brain and retinal energy homeostasis. Subcell. Biochem. 46: 83–98.
Tarnopolsky, M.A., Bourgeois, J.M., Snow, R., Keys, S., Roy, B.D., Kwiecien, J.M., and Turnbull, J., 2003, Histological assessment of intermediate- and long-term creatine monohydrate supplementation in mice and rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285: R762–R769.
Torremans, A., Marescau, B., Possemiers, I., Van Dam, D., D’Hooge, R., Isbrandt, D., and De Deyn, P.P., 2005, Biochemical and behavioural phenotyping of a mouse model for GAMT deficiency. J. Neurol. Sci. 231: 49–55.
Volpe, J.J., 2001, Neurology of the Newborn, Saunders, Philadelphia.
Walker, J.B., 1979, Creatine: biosynthesis, regulation, and function. Adv. Enzymol. Relat. Areas Mol. Biol. 50: 177–242.
Wang, Y.E., Esbensen, P., and Bentley, D., 1998, Arginine kinase expression and localization in growth cone migration. J. Neurosci. 18: 987–998.
Wyss, M., and Kaddurah-Daouk, R., 2000, Creatine and creatinine metabolism. Physiol. Rev. 80: 1107–1213.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer
About this chapter
Cite this chapter
Stockler, S., Schutz, P.W., Salomons, G.S. (2007). Cerebral Creatine Deficiency Syndromes: Clinical Aspects, Treatment and Pathophysiology. In: Salomons, G.S., Wyss, M. (eds) Creatine and Creatine Kinase in Health and Disease. Subcellular Biochemistry, vol 46. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-6486-9_8
Download citation
DOI: https://doi.org/10.1007/978-1-4020-6486-9_8
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-6485-2
Online ISBN: 978-1-4020-6486-9
eBook Packages: MedicineMedicine (R0)